As the Congo faces a severe Mpox outbreak, the first shipment of monkeypox vaccines from the United States is expected to arrive next week.
This comes shortly after the World Health Organisation (WHO) declared the outbreak a global health emergency, highlighting the critical need for intervention.
The Congo, currently bearing the brunt of the outbreak, urgently requires three million vaccine doses to control the spread of the virus.
However, vaccine supplies remain scarce. In addition to the U.S. shipment, Japan has pledged to donate vaccines, although specific details on the quantity and delivery schedule are yet to be confirmed.
According to the Africa Centers for Disease Control and Prevention (Africa CDC), the outbreak has led to over 17,500 confirmed and suspected Mpox cases and 524 deaths across 13 African countries. The Congo is the hardest hit, with women and children under 15 being particularly vulnerable to the virus.
The situation has taken on an international dimension as a new strain of monkeypox recently spread beyond Africa. Sweden has reported a case in a traveler from the Congo, prompting the U.S. Centers for Disease Control and Prevention (CDC) to issue a health alert. The CDC advises healthcare providers to monitor patients who have recently traveled to the Congo or neighboring regions for symptoms. Despite this, the CDC considers the risk of the new strain reaching the U.S. to be very low due to the limited number of travelers and the absence of direct commercial flights from the affected areas.
The WHO’s emergency declaration aims to increase global awareness and mobilize resources, including vaccines and treatments, to support the regions affected by the outbreak. The new strain of Mpox is particularly concerning due to its higher fatality rate, which stands at approximately 3 percent, compared to 0.2 percent during the 2022 outbreak.
As the Congo prepares for the arrival of the first vaccine doses, health experts stress the importance of swift and coordinated international action to prevent further spread of the virus. The Africa CDC estimates that over 10 million doses are needed to bring the outbreak under control. The imminent arrival of these initial vaccines represents a critical step in addressing what has become an increasingly dire health crisis.
